Arch Biopartners (TSXV:ARCH) Tax Rate % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Arch Biopartners's Tax Expense for the three months ended in Dec. 2023 was C$0.00 Mil. Arch Biopartners's Pre-Tax Income for the three months ended in Dec. 2023 was C$-0.78 Mil. Therefore, Arch Biopartners's Tax Rate % for the quarter that ended in Dec. 2023 was 0.00%.

Arch Biopartners Tax Rate % Historical Data

The historical data trend for Arch Biopartners's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Tax Rate % Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Tax Rate %

Get a 7-Day Free Trial

Arch Biopartners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

Arch Biopartners Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Arch Biopartners's Tax Rate % for the fiscal year that ended in Sep. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Sep. 2023 )	/	Pre-Tax Income (A: Sep. 2023 )
	=	0	/	-3.327
	=	0.00 %

Arch Biopartners's Tax Rate % for the quarter that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2023 )	/	Pre-Tax Income (Q: Dec. 2023 )
	=	0	/	-0.783
	=	0.00 %

Arch Biopartners Tax Rate % Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.